Trademark: 79138122
Status Date
Wednesday, May 12, 2021
Registration Number
4607742
Registration Date
Tuesday, September 23, 2014
Filing Date
Friday, February 15, 2013
Published for Opposition
Tuesday, July 8, 2014
9 computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information concerning the quality, safety and effectiveness of medications and/or pharmaceuticals and reactions and events resulting from the use of medications and/or pharmaceuticals; computer software for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said quality, reactions and events and producing reports regarding such quality, reactions and events; computer programs for capturing and providing information concerning the quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said quality, reactions and events and for producing reports regarding such quality, reactions and events; computer software applications for capturing information concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; computer software for the evaluation and analysis of data and information concerning the quality, safety and effectiveness of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication and/or pharmaceuticals
38 Telecommunications services, namely, transmission of data by means of telecommunications networks, wireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunication; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunication services, namely, electronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication services, namely, providing access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companies
42 software as a service (SAAS) services featuring software for capturing and providing data concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; software as a service (SAAS) services featuring software for evaluating and analysing data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication or pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use medication and/or pharmaceuticals, as well as enabling followup questions and answers regarding said quality, reactions and events and enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning the quality of medication and/or pharmaceuticals used, reactions and events resulting from the use of medication and/or pharmaceuticals, answer (and read answers to) follow-up questions regarding said quality, reactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collecting, evaluating and analysing data concerning the quality of medication and/or pharmaceuticals used, reactions and events resulting from the use of medication and/or pharmaceuticals
Sep 23, 2023
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Aug 21, 2023
Teas Change Of Correspondence Received
Aug 21, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 21, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 3, 2023
International Registration Renewed
May 12, 2021
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
May 12, 2021
Registered - Sec. 71 Accepted & Sec. 15 Ack.
Jan 5, 2021
Case Assigned To Post Registration Paralegal
Sep 23, 2020
Teas Section 71 & 15 Received
Mar 13, 2015
Final Decision Transaction Processed By Ib
Feb 26, 2015
Final Disposition Notice Sent To Ib
Feb 26, 2015
Final Disposition Processed
Dec 23, 2014
Final Disposition Notice Created, To Be Sent To Ib
Sep 23, 2014
Registered-Principal Register
Jul 22, 2014
Notification Processed By Ib
Jul 8, 2014
Published For Opposition
Jul 2, 2014
Notification Of Possible Opposition Sent To Ib
Jul 2, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 18, 2014
Notice Of Publication
May 31, 2014
Law Office Publication Review Completed
May 31, 2014
Assigned To Lie
May 19, 2014
Approved For Pub - Principal Register
May 16, 2014
Teas/Email Correspondence Entered
May 15, 2014
Correspondence Received In Law Office
May 15, 2014
Teas Response To Office Action Received
Dec 10, 2013
Refusal Processed By Ib
Nov 19, 2013
Application Filing Receipt Mailed
Nov 15, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Nov 14, 2013
Refusal Processed By Mpu
Nov 14, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Nov 13, 2013
Non-Final Action Written
Nov 13, 2013
Assigned To Examiner
Nov 13, 2013
New Application Office Supplied Data Entered
Nov 12, 2013
Limitation From Original Application Entered
Nov 11, 2013
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
